|
|
|
|
|
|
|
|
| Industry Trends |
|
|
Pharm Exec's Top 50 Companies 2017 |
Pharm Exec's 17th annual listing of the top biopharma players paints a stable picture of performance for the usual placeholders, but change and disruption to current business models could upend positioning in the years ahead.
... /Read more/ |
|
|
|
|
| Advertisement |
The Changing Market for Drugs to Treat Orphan Diseases
Live Webinar: Tuesday, July 18 at 10am EDT
 Register now
|
|
| Advertisement |
Through the Patient's Eyes - Needs, Behaviors and the Science Behind it All
On Demand
 Learn more
|
|
| Advertisement |
Emerging Biopharma and Rare Disease: Finding a Needle in a Haystack
Data-driven Patient Recruitment Solutions
On Demand
 Learn more
|
|
| Advertisement |
Talking the Patients' Language – the importance of effective, patient-centered engagement
On Demand
 Learn more
|
|
|
| Advertisement |
THE IMPORTANCE OF STAKEHOLDER RESEARCH IN RARE DISEASE DRUG DEVELOPMENT
The approval of novel orphan drug designations continues to grow, while many existing rare disease therapies are receiving approval for expanded indications. With this increase Rare Disease Drug Development and broadening class of products, including some that target the same mutation or molecular defect, sponsors face new and significant market access challenges in securing reimbursement. Sponsored by Covance.
 Learn more
|
| Calendar |
|
| Advertisement |
Coming to terms with Patient Centricity
On Demand
 Learn more
|
|
 |
|
|
| Advertisement |
Launch Excellence V: Surviving and thriving in a specialized world
On Demand
 Learn more
|
|
|
|
|
|
|
|
